Seeking Solutions to Fight Alzheimer's through Early Detection of Mild Cognitive Impairment (MCI)Keywords
Mild Cognitive Impairment, Alzheimer's, Screening, Devices, Dementia
DANONE NUTRICIA RESEARCH
Up to 890,000 people suffer from Mild Cognitive Impairment (MCI) in Australia and New Zealand, and this number is set to grow as the population ages. In many cases, MCI represents a transitional state between normal ageing and Alzheimer’s disease, and is characterised by a cognitive decline that is greater than expected based on a person’s age. Typically, people don’t know they have MCI until it is too late and has progressed to Alzheimer’s disease.
We are looking for an affordable and scalable technological solution that can help screen for MCI in older adults, and potentially connect these older adults to healthcare professionals e.g. General Practitioners familiar with MCI or specialist physicians eg. geriatrician, neurologist or psychogeriatrician.
Expensive and cumbersome devices